Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction

被引:32
作者
Albrecht, B
Collins, ND
Newbound, GC
Ratner, L
Lairmore, MD [1 ]
机构
[1] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA
[4] Ohio State Univ, Arthur James Canc Hosp & Res Inst, Ctr Comprehens Canc, Columbus, OH 43210 USA
[5] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[7] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
关键词
HTLV-1; quantitative competitive polymerase chain reaction; pathogenesis; animal model; diagnosis; retrovirus;
D O I
10.1016/S0166-0934(98)00087-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The polymerase chain reaction (PCR) has been established as a highly sensitive technique for detection of viral DNA or RNA. However, due to inherent limitations of PCR the amount of amplified product often does not correlate with the initial amount of template DNA. This is particularly true for PCR detection of viral infections that are characterized by low in vivo viral copy numbers in certain stages of the infection, such as human T-cell lymphotropic virus type 1 (HTLV-1) and simian T-cell lymphotropic virus type 1 (STLV-1). Therefore, we developed a quantitative competitive polymerase chain reaction (qcPCR) for detection of HTLV-1 and STLV-1 proviral DNA. The assay was optimized using an infectious HTLV-1 clone, AGH, HTLV-1 infected cell lines, MT-2.6 and HUT-102 and STLV-1 infected lines Kia and Matsu. Applicability of this system was demonstrated by determining HTLV-1 proviral load in peripheral blood mononuclear cells (PBMC) of human subjects with HTLV-1 associated diseases and an asymptomatic carrier as well as rabbits infected experimentally. This qcPCR method, the first designed specifically for HTLV-1 and STLV-1, will provide an important tool for pathogenesis studies of HTLV-1 and for evaluating the efficacy of antiviral drugs and vaccines against the viral infection using animal models. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:123 / 140
页数:18
相关论文
共 66 条
[1]   ENZYMATIC GENE AMPLIFICATION - QUALITATIVE AND QUANTITATIVE METHODS FOR DETECTING PROVIRAL DNA AMPLIFIED INVITRO [J].
ABBOTT, MA ;
POIESZ, BJ ;
BYRNE, BC ;
KWOK, S ;
SNINSKY, JJ ;
EHRLICH, GD .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1158-1169
[2]   MOLECULAR PROFILE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN SYMPTOMLESS PATIENTS AND IN PATIENTS WITH AIDS [J].
BAGNARELLI, P ;
MENZO, S ;
VALENZA, A ;
MANZIN, A ;
GIACCA, M ;
ANCARANI, F ;
SCALISE, G ;
VARALDO, PE ;
CLEMENTI, M .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7328-7335
[3]   HUMAN T-CELL-LEUKEMIA VIRUS TYPE-I IN POSTTRANSFUSIONAL SPASTIC PARAPARESIS - COMPLETE PROVIRAL SEQUENCE FROM UNCULTURED BLOOD-CELLS [J].
BAZARBACHI, A ;
HUANG, M ;
GESSAIN, A ;
SAAL, F ;
SAIB, A ;
PERIES, J ;
DETHE, H ;
GALIBERT, F .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (04) :494-499
[4]  
CIMARELLI A, 1994, J ACQ IMMUN DEF SYND, V7, P230
[5]   QUANTIFICATION OF HTLV-II PROVIRAL COPIES BY COMPETITIVE POLYMERASE CHAIN-REACTION IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF ITALIAN INJECTING DRUG-USERS, CENTRAL AFRICANS, AND AMERINDIANS [J].
CIMARELLI, A ;
DUCLOS, CA ;
GESSAIN, A ;
CATTANEO, E ;
CASOLI, C ;
BIGLIONE, M ;
MAUCLERE, P ;
BERTAZZONI, U .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (02) :198-204
[6]   QUANTITATIVE MOLECULAR METHODS IN VIROLOGY [J].
CLEMENTI, M ;
MENZO, S ;
MANZIN, A ;
BAGNARELLI, P .
ARCHIVES OF VIROLOGY, 1995, 140 (09) :1523-1539
[7]   COMPETITIVE POLYMERASE CHAIN-REACTION AND ANALYSIS OF VIRAL ACTIVITY AT THE MOLECULAR-LEVEL [J].
CLEMENTI, M ;
BAGNARELLI, P ;
MANZIN, A ;
MENZO, S .
GENETIC ANALYSIS-BIOMOLECULAR ENGINEERING, 1994, 11 (01) :1-6
[8]   PERSISTENT INFECTION OF RABBITS WITH HTLV-I - PATTERNS OF ANTI-VIRAL ANTIBODY REACTIVITY AND DETECTION OF VIRUS BY GENE AMPLIFICATION [J].
COCKERELL, GL ;
LAIRMORE, M ;
DE, B ;
ROVNAK, J ;
HARTLEY, TM ;
MIYOSHI, I .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (01) :127-130
[9]   Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo [J].
Collins, ND ;
Newbound, GC ;
Albrecht, B ;
Beard, JL ;
Ratner, L ;
Lairmore, MD .
BLOOD, 1998, 91 (12) :4701-4707
[10]   In vitro CD4(+) lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotropic virus type 1 [J].
Collins, ND ;
Newbound, GC ;
Ratner, L ;
Lairmore, MD .
JOURNAL OF VIROLOGY, 1996, 70 (10) :7241-7246